Tapewire

Nasdaq · USD

COLL

COLLEGIUM PHARMACEUTICAL, INC

Export transactions ↓
Tapewire entity
5169
SEC CIK
0001267565
Parsed reports
359

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 15, 2021 Filed Jan 20, 2021 21:15 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 1,322 $22.89 $30,260.58
Disclosure

SEC source: 0001192482-21-000063 · edgar.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,395

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020 and amended on December 7, 2020.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:08 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 701 $21.18 $14,847.18
Disclosure

SEC source: 0001192482-21-000058 · edgar.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,717

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 17:06 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 16,042 $0.00 Strike: $5.73 $0.00
Disclosure

SEC source: 0001192482-21-000050 · edgar.xml · derivative · entry 6

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,042 shares

Expires 2025-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option was fully vested and exercisable as of January 7, 2021.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 17:06 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 16,042 $22.00 $352,924.00
Disclosure

SEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 4

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,419

F3 · kind: The sales occurring on January 7, 2021 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 17:06 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 16,042 $5.73 $91,920.66
Disclosure

SEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 3

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,461

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 21:09 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 1,090 $20.03 $21,832.70
Disclosure

SEC source: 0001192482-21-000045 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,256

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
December 03, 2020 Filed Dec 7, 2020 16:03 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 5,967 $19.24 $114,805.08
Disclosure

SEC source: 0001192482-20-000799 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,419

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.03 to $19.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
November 30, 2020 Filed Dec 2, 2020 22:00 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 4,672 $18.49 $86,385.28
Disclosure

SEC source: 0001192482-20-000797 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,346

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
November 18, 2020 Filed Nov 20, 2020 16:28 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 16,000 $0.00 Strike: $5.73 $0.00
Disclosure

SEC source: 0001192482-20-000793 · edgar.xml · derivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,378

Underlying: Common Stock · 16,000 shares

Expires 2025-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option was fully vested and exercisable as of November 18, 2020.

Read SEC document
November 18, 2020 Filed Nov 20, 2020 16:28 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 16,000 $5.73 $91,680.00
Disclosure

SEC source: 0001192482-20-000793 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 15, 2020 Filed Oct 16, 2020 16:07 UTC
Kuhlmann Shirley R.EVP and General Counsel
SaleCommon Stock 7,060 $20.82 $146,989.20
Disclosure

SEC source: 0001192482-20-000777 · edgar.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,531

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2020 and modified on September 15, 2020.

Read SEC document
September 24, 2020 Filed Sep 28, 2020 21:49 UTC GrantStock Option (Right to Purchase) · Derivative 10,055 $0.00 Strike: $17.77 $0.00
Disclosure

SEC source: 0001192482-20-000713 · edgar.xml · derivative · entry 2

Balice-Gordon Rita J. · CIK 0001825625 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,055

Underlying: Common Stock · 10,055 shares

Expires 2030-09-24

F2 · derivative.exercise_date: The option vests and becomes exercisable on September 24, 2021, subject to the director's continued service with the issuer.

Read SEC document
September 24, 2020 Filed Sep 28, 2020 21:49 UTC GrantCommon Stock 5,027 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000713 · edgar.xml · nonDerivative · entry 1

Balice-Gordon Rita J. · CIK 0001825625 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,027

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on September 24, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 16:17 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 734 $19.33 $14,188.22
Disclosure

SEC source: 0001192482-20-000703 · edgar.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,591

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 11, 2020 Filed Aug 12, 2020 20:05 UTC SaleCommon Stock 13,071 $19.13 $250,048.23
Disclosure

SEC source: 0001192482-20-000666 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,122

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2019.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.72 to $19.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 16:04 UTC
Fleming Alison BChief Technology Officer
Tax withholdingCommon Stock 1,515 $18.89 $28,618.35
Disclosure

SEC source: 0001192482-20-000665 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,386

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 20:05 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 1,386 $18.89 $26,181.54
Disclosure

SEC source: 0001192482-20-000667 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,018

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 20:06 UTC
Brannelly PaulExecutive Vice President & CFO
Tax withholdingCommon Stock 1,515 $18.89 $28,618.35
Disclosure

SEC source: 0001192482-20-000668 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,758

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
July 13, 2020 Filed Jul 14, 2020 20:06 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 1,429 $17.01 $24,307.29
Disclosure

SEC source: 0001192482-20-000621 · edgar.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,418

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019.

Read SEC document
July 10, 2020 Filed Jul 14, 2020 20:06 UTC
Dreyer ScottEVP & Chief Commercial Officer
Tax withholdingCommon Stock 594 $16.73 $9,937.62
Disclosure

SEC source: 0001192482-20-000621 · edgar.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,847

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:40 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 1,394 $17.37 $24,213.78
Disclosure

SEC source: 0001192482-20-000600 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,404

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
June 02, 2020 Filed Jun 2, 2020 22:58 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 100 $21.30 $2,130.00
Disclosure

SEC source: 0001192482-20-000418 · edgar.xml · nonDerivative · entry 6

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,798

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.

Read SEC document
June 02, 2020 Filed Jun 2, 2020 22:58 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 5,761 $20.47 $117,927.67
Disclosure

SEC source: 0001192482-20-000418 · edgar.xml · nonDerivative · entry 5

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,898

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.18 to $20.92, inclusive.

Read SEC document
June 01, 2020 Filed Jun 2, 2020 22:58 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionStock Option (Right to Purchase) · Derivative 64,820 $0.00 Strike: $8.22 $0.00
Disclosure

SEC source: 0001192482-20-000418 · edgar.xml · derivative · entry 7

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,821

Underlying: Common Stock · 64,820 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 64,820 shares under the option are exercisable. The option, initially representing a right to purchase a total of 259,283 shares, vests and becomes exercisable over a four-year period commencing on May 31, 2017. Twenty-five percent (25%) of the option vested and became exercisable on May 31, 2018 and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) at the end of each quarterly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the Issuer.

Read SEC document
June 01, 2020 Filed Jun 2, 2020 22:58 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 100 $22.08 $2,208.00
Disclosure

SEC source: 0001192482-20-000418 · edgar.xml · nonDerivative · entry 4

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,659

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.

Read SEC document
June 01, 2020 Filed Jun 2, 2020 22:58 UTC
Ciaffoni JosephDirector · President and CEO
SaleCommon Stock 70,576 $21.53 $1,519,501.28
Disclosure

SEC source: 0001192482-20-000418 · edgar.xml · nonDerivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,759

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.05 to $22.02, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4).

Read SEC document
June 01, 2020 Filed Jun 2, 2020 22:58 UTC
Ciaffoni JosephDirector · President and CEO
Exercise / conversionCommon Stock 64,820 $8.22 $532,820.40
Disclosure

SEC source: 0001192482-20-000418 · edgar.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,335

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2020 Filed Jun 2, 2020 22:58 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 4,672 $21.24 $99,233.28
Disclosure

SEC source: 0001192482-20-000418 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,515

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:25 UTC GrantStock Option (Right to Purchase) · Derivative 8,095 $0.00 Strike: $22.05 $0.00
Disclosure

SEC source: 0001192482-20-000367 · edgar.xml · derivative · entry 3

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 8,095 shares

Expires 2030-05-20

F3 · derivative.exercise_date: The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:25 UTC GrantCommon Stock 4,047 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000367 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,193

F2 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:25 UTC Tax withholdingCommon Stock 18,650 $22.05 $411,232.50
Disclosure

SEC source: 0001192482-20-000367 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,146

F1 · shares: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:22 UTC GrantStock Option (Right to Purchase) · Derivative 8,095 $0.00 Strike: $22.05 $0.00
Disclosure

SEC source: 0001192482-20-000363 · edgar.xml · derivative · entry 2

Schroeder Theodore R · CIK 0001378690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 8,095 shares

Expires 2030-05-20

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:22 UTC GrantCommon Stock 4,047 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000363 · edgar.xml · nonDerivative · entry 1

Schroeder Theodore R · CIK 0001378690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,007

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:23 UTC GrantStock Option (Right to Purchase) · Derivative 8,095 $0.00 Strike: $22.05 $0.00
Disclosure

SEC source: 0001192482-20-000365 · edgar.xml · derivative · entry 4

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 8,095 shares

Expires 2030-05-20

F4 · derivative.exercise_date: The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:23 UTC GrantCommon Stock 4,047 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000365 · edgar.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,007

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:26 UTC
SANTINI GINODirector
GrantStock Option (Right to Purchase) · Derivative 8,095 $0.00 Strike: $22.05 $0.00
Disclosure

SEC source: 0001192482-20-000368 · edgar.xml · derivative · entry 2

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 8,095 shares

Expires 2030-05-20

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:26 UTC
SANTINI GINODirector
GrantCommon Stock 4,047 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000368 · edgar.xml · nonDerivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,195

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:24 UTC
Hirsch DavidDirector
GrantStock Option (Right to Purchase) · Derivative 8,095 $0.00 Strike: $22.05 $0.00
Disclosure

SEC source: 0001192482-20-000366 · edgar.xml · derivative · entry 2

Hirsch David · CIK 0001619884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 8,095 shares

Expires 2030-05-20

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:24 UTC
Hirsch DavidDirector
GrantCommon Stock 4,047 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000366 · edgar.xml · nonDerivative · entry 1

Hirsch David · CIK 0001619884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,164

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:23 UTC GrantStock Option (Right to Purchase) · Derivative 8,095 $0.00 Strike: $22.05 $0.00
Disclosure

SEC source: 0001192482-20-000364 · edgar.xml · derivative · entry 2

Fallon John A. · CIK 0001560152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 8,095 shares

Expires 2030-05-20

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:23 UTC GrantCommon Stock 4,047 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000364 · edgar.xml · nonDerivative · entry 1

Fallon John A. · CIK 0001560152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,382

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:21 UTC GrantStock Option (Right to Purchase) · Derivative 8,095 $0.00 Strike: $22.05 $0.00
Disclosure

SEC source: 0001192482-20-000362 · edgar.xml · derivative · entry 2

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 8,095 shares

Expires 2030-05-20

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:21 UTC GrantCommon Stock 4,047 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000362 · edgar.xml · nonDerivative · entry 1

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,007

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:20 UTC GrantStock Option (Right to Purchase) · Derivative 8,095 $0.00 Strike: $22.05 $0.00
Disclosure

SEC source: 0001192482-20-000361 · edgar.xml · derivative · entry 2

BOHLIN GAREN G · CIK 0001254705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 8,095 shares

Expires 2030-05-20

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:20 UTC GrantCommon Stock 4,047 $0.00 $0.00
Disclosure

SEC source: 0001192482-20-000361 · edgar.xml · nonDerivative · entry 1

BOHLIN GAREN G · CIK 0001254705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,007

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Read SEC document
May 18, 2020 Filed May 20, 2020 20:18 UTC
Dreyer ScottEVP & Chief Commercial Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 8,000 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001192482-20-000350 · edgar.xml · derivative · entry 3

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,600

Underlying: Common Stock · 8,000 shares

Expires 2029-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 8,000 shares under the option are exercisable. The option, initially representing a right to purchase a total of 25,600 shares, vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vested and became exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
May 18, 2020 Filed May 20, 2020 20:18 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 8,000 $24.00 $192,000.00
Disclosure

SEC source: 0001192482-20-000350 · edgar.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019 and modified on March 5, 2020.

Read SEC document
May 18, 2020 Filed May 20, 2020 20:18 UTC
Dreyer ScottEVP & Chief Commercial Officer
Exercise / conversionCommon Stock 8,000 $15.90 $127,200.00
Disclosure

SEC source: 0001192482-20-000350 · edgar.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,441

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 13, 2020 Filed May 15, 2020 16:16 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 2,728 $22.74 $62,034.72
Disclosure

SEC source: 0001192482-20-000347 · edgar.xml · nonDerivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,901

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.19 to $22.98, inclusive.

Read SEC document
May 13, 2020 Filed May 15, 2020 16:16 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 5,261 $21.12 $111,112.32
Disclosure

SEC source: 0001192482-20-000347 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,629

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.89 to $21.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.